Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James F Markmann

Showing results (251-260 of 266) with videos related to

Pageof 27
Sort By:
Cell Transplantation|March 1, 2016
A Multicenter Study: North American Islet Donor Score in Donor Pancreas Selection for Human Islet Isolation for TransplantationLing-Jia Wang, Tatsuya Kin, Doug O'Gorman, et al.
JAMA Surgery|January 5, 2022
Impact of Portable Normothermic Blood-Based Machine Perfusion on Outcomes of Liver Transplant: The OCS Liver PROTECT Randomized Clinical TrialJames F Markmann, Marwan S Abouljoud, R Mark Ghobrial, et al.
Science (New York, N.Y.)|July 17, 2025
A hypoxia-responsive tRNA-derived small RNA confers renal protection through RNA autophagyGuoping Li, Lingfei Sun, Cuiyan Xin, et al.
Diabetes|July 29, 2016
National Institutes of Health-Sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: Manufacture of a Complex Cellular Product at Eight Processing FacilitiesCamillo Ricordi, Julia S Goldstein, A N Balamurugan, et al.
Diabetes|July 1, 2017
Erratum. National Institutes of Health-Sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: Manufacture of a Complex Cellular Product at Eight Processing Facilities. Diabetes 2016;65:3418-3428Camillo Ricordi, Julia S Goldstein, A N Balamurugan, et al.
The New England Journal of Medicine|June 3, 2026
Kidney Transplantation in Two Highly Sensitized Candidates after CAR T-Cell TherapyVijay G Bhoj, Mary Kaminski, Huiwu Zhao, et al.
Hepatology (Baltimore, Md.)|March 4, 2020
Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan CriteriaAni Kardashian, Sander S Florman, Brandy Haydel, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 11, 2020
Posttransplant Outcomes in Older Patients With Hepatocellular Carcinoma Are Driven by Non-Hepatocellular Carcinoma FactorsNia Adeniji, Vinodhini Arjunan, Vijay Prabhakar, et al.
Cell Metabolism|June 5, 2024
Glucagon-like peptide 1 receptor is a T cell-negative costimulatory moleculeMoufida Ben Nasr, Vera Usuelli, Sergio Dellepiane, et al.
Annals of Surgery|March 15, 2019
Pathologic Response to Pretransplant Locoregional Therapy is Predictive of Patient Outcome After Liver Transplantation for Hepatocellular Carcinoma: Analysis From the US Multicenter HCC Transplant ConsortiumJoseph DiNorcia, Sander S Florman, Brandy Haydel, et al.
Pageof 27

Showing results (251-260 of 266) with videos related to

Sort By:
Pageof 27
Cell Transplantation|March 1, 2016
A Multicenter Study: North American Islet Donor Score in Donor Pancreas Selection for Human Islet Isolation for TransplantationLing-Jia Wang, Tatsuya Kin, Doug O'Gorman, et al.
JAMA Surgery|January 5, 2022
Impact of Portable Normothermic Blood-Based Machine Perfusion on Outcomes of Liver Transplant: The OCS Liver PROTECT Randomized Clinical TrialJames F Markmann, Marwan S Abouljoud, R Mark Ghobrial, et al.
Science (New York, N.Y.)|July 17, 2025
A hypoxia-responsive tRNA-derived small RNA confers renal protection through RNA autophagyGuoping Li, Lingfei Sun, Cuiyan Xin, et al.
Diabetes|July 29, 2016
National Institutes of Health-Sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: Manufacture of a Complex Cellular Product at Eight Processing FacilitiesCamillo Ricordi, Julia S Goldstein, A N Balamurugan, et al.
Diabetes|July 1, 2017
Erratum. National Institutes of Health-Sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: Manufacture of a Complex Cellular Product at Eight Processing Facilities. Diabetes 2016;65:3418-3428Camillo Ricordi, Julia S Goldstein, A N Balamurugan, et al.
The New England Journal of Medicine|June 3, 2026
Kidney Transplantation in Two Highly Sensitized Candidates after CAR T-Cell TherapyVijay G Bhoj, Mary Kaminski, Huiwu Zhao, et al.
Hepatology (Baltimore, Md.)|March 4, 2020
Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan CriteriaAni Kardashian, Sander S Florman, Brandy Haydel, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 11, 2020
Posttransplant Outcomes in Older Patients With Hepatocellular Carcinoma Are Driven by Non-Hepatocellular Carcinoma FactorsNia Adeniji, Vinodhini Arjunan, Vijay Prabhakar, et al.
Cell Metabolism|June 5, 2024
Glucagon-like peptide 1 receptor is a T cell-negative costimulatory moleculeMoufida Ben Nasr, Vera Usuelli, Sergio Dellepiane, et al.
Annals of Surgery|March 15, 2019
Pathologic Response to Pretransplant Locoregional Therapy is Predictive of Patient Outcome After Liver Transplantation for Hepatocellular Carcinoma: Analysis From the US Multicenter HCC Transplant ConsortiumJoseph DiNorcia, Sander S Florman, Brandy Haydel, et al.
Pageof 27